$CCRN

Nevin Janice Elizabeth sold (to issuer) $644K of CCRN

Nevin Janice Elizabeth sold (to issuer) 48,616 shares of CROSS COUNTRY HEALTHCARE INC (CCRN) at $13.25 ($0.64M total) on 2026-07-21.

Original reporting
SEC EDGAR · Nevin Janice Elizabeth
Published Jul 21, 2026, 8:10 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jul 21, 2026, 8:11 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefInsider activity
Primary signal
$CCRN
Neutral
medium confidence
Mentioned
$CCRN
Relevance
5/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$CCRNNeutralLow
01

Why it matters

Insider selling can affect short-term sentiment, but this filing does not include any new company-specific operating or financial information.

02

Market read

Traders may note the insider sale for sentiment monitoring, but it is unlikely to drive a durable repricing without accompanying fundamental news.

03

What to watch

No 10b5-1 plan is indicated, but the filing does not explain motive, tax timing, or whether the transaction is part of a structured corporate program.

Relevance 5/10Novelty 3/10Timing: filed after-hours on 2026-07-21 (SEC Form 4 disclosure)

Background

The article is an SEC Form 4 insider transaction disclosure for Cross Country Healthcare (CCRN).

Company-level read

Ticker impact

$CCRNNeutralMedium confidence
Context

Form 4 shows director Nevin Janice Elizabeth sold 48,616 shares to the issuer at $13.25 on 2026-07-21, leaving 0 shares.

Expected impact

Likely minimal near-term impact; any effect would be sentiment-only and typically fades quickly.

Evidence & confidence

The filing is a primary-source insider transaction, but it provides no earnings, guidance, contract, or regulatory catalyst. The transaction size is moderate and the post-sale holding is 0 shares, which can be interpreted either as diversification or liquidity rather than a directional signal.

Market effects

No clear sector read-through from a single director sale to the issuer.

None.

None.

Counterpoint

The sale is to the issuer (often buyback participation or similar mechanics), which can be non-informational versus open-market selling.

Key entities

  • CROSS COUNTRY HEALTHCARE INC

    Company whose director insider transaction is disclosed on Form 4.

  • Nevin Janice Elizabeth

    Director who sold 48,616 shares to the issuer at $13.25 on 2026-07-21.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$LWAYLow

Divisadero Street Capital Management, LP (Zolezzi William) purchased $6.1M of LWAY (indirect holdings)

Divisadero Street Capital Management, LP purchased 246,568 indirectly-held shares of Lifeway Foods, Inc. (LWAY) at an average of $24.85 ($24.69–$24.87, $6.13M total) across 3 trades over 2026-08-13 to 2026-08-17. Filed jointly with Divisadero Street Partners GP, LLC (10% owner), Divisadero Street Capital, LLC (10% owner), Divisadero Street Partners, L.P. (10% owner) and Zolezzi William (10% owner).